Related Experiment Video
Updated: Aug 9, 2026

07:26
BioMEMS: Forging New Collaborations Between Biologists and Engineers
Published on: November 1, 2007
Building Tomorrow's Biomanufacturing Workforce: A Dual Framework for Internal Development and External Partnerships:
1Jubilant HollisterStier Adam.Snider@jubl.com.
PDA Journal of Pharmaceutical Science and Technology
|August 7, 2026
Summary
A dual framework enhances workforce development by cross-training employees and partnering with local colleges. This strategy builds a skilled pipeline for biomanufacturing, ensuring quality and safety during operational scaling.
Area of Science:
- Biomanufacturing
- Workforce Development
- Operational Scaling
Background:
- Developing a skilled workforce is essential for scaling operations while maintaining quality and safety standards in biomanufacturing.
- The biopharmaceutical industry requires a robust talent pipeline to meet increasing production demands.
Purpose of the Study:
- To present a dual framework for workforce development in biomanufacturing.
- To detail strategies for internal training and external outreach to build a skilled workforce pipeline.
Main Methods:
- Implementing a shared resource model and cross-training employees to perform multiple roles.
- Establishing partnerships with local academic institutions and economic development organizations.
- Creating a biotech manufacturing certification course with a community college.
Main Results:
- Achieved continuous 24-hour operations through improved flexibility and technician deployment.
- Enhanced operational efficiency and readiness for scaling production.
- Prepared individuals with foundational skills for careers in pharmaceutical manufacturing.
Conclusions:
- A dual approach combining internal cross-training and external partnerships effectively develops a skilled biomanufacturing workforce.
- This model supports operational scaling, enhances flexibility, and ensures high standards of quality and safety.
- Investing in targeted training programs is crucial for future talent acquisition in the biopharmaceutical sector.

